SULFLUX DSR Capsules – Pantoprazole (EC) 40 mg + Domperidome (SR) I.P. 30 mg
Description:
This Pantoprazole Gastro-Resistant & Domperidone Prolonged Release Capsules IP combination is formulated for managing enhanced acid suppression and gastric motility improvement. It combines, Pantoprazole, a proton pump inhibitor (PPI) that inhibits the H+/K+ ATPase pump, effectively reducing stomach acid production; with Domperidone, a dopamine D2 receptor antagonist that promotes gastric emptying and prevents nausea & bloating by blocking dopamine receptors in the gut.
Key points
✅Effective GERD Management: Provides rapid and sustained relief from symptoms of gastroesophageal reflux disease, heartburn, acidity, and indigestion.
✅Enhanced Prokinetic Action: The dual-release Domperidone formulation provides rapid relief by promoting gastric emptying while maintaining prolonged motility support, helping to minimize bloating, nausea, and reflux episodes.
✅Superior activity than PPI Alone: This synergistic combination not only controls acid secretion but also improves gastric motility, delivering quicker and more sustained relief than proton pump inhibitor therapy alone.
Targeted specialties
✅Gastroenterologists
✅General Physicians
Disclaimer: To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion











